author-photo

Maria Blasinska-Morawiec

Memorial Hospital of South Bend

23

Papers

4102

Citations

Citation Trend

Filter By

Papers (23) Sort By

Journal Conference Others

Analysis of KRAS/NRAS and BRAF mutations in the phase III PRIME study of panitumumab (pmab) plus FOLFOX versus FOLFOX as first-line treatment (tx) for metastatic colorectal cancer (mCRC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (48)
Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study

2017 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (7)
Biomarker analyses from the phase III placebo-controlled SATURN study of maintenance erlotinib following first-line chemotherapy for advanced NSCLC

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (54)
A phase II study of pemetrexed and doxorubicin in patients with advanced or metastatic breast cancer (MBC)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (333)
403PPHASE II STUDY EVALUATING ORAL VINORELBINE AS A SINGLE-AGENT AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST CANCER PATIENTS WITH BONE METASTASES (NORBREAST-228 TRIAL): FIRST EFFICACY RESULTS

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
First safety results of an international phase II study evaluating oral vinorelbine as a single agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreast-228 trial).

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase III Trial of Sunitinib in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Patients With Pretreated Metastatic Breast Cancer

2013 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (123)
Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer

2013 The Breast
Show All
- Source
- Cite
- Save
Citations (7)
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

2013 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (1612)